MX2009010886A - Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa. - Google Patents
Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa.Info
- Publication number
- MX2009010886A MX2009010886A MX2009010886A MX2009010886A MX2009010886A MX 2009010886 A MX2009010886 A MX 2009010886A MX 2009010886 A MX2009010886 A MX 2009010886A MX 2009010886 A MX2009010886 A MX 2009010886A MX 2009010886 A MX2009010886 A MX 2009010886A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitors
- disorders
- nase
- phosphatidylinositol
- pyrimidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Dental Preparations (AREA)
Abstract
La invención proporciona compuestos que son pirimidinas de la fórmula (i): en donde R1, R2 son como se definen en la presente, y/o una sal farmacéuticamente aceptable de los mismos. Estos compuestos son inhibidores de PI3K y de esta manera se pueden usar para tratar enfermedades y trastornos que surgen del crecimiento, función o comportamiento celular anormal asociado con PI3-cinasa tal como cáncer, trastornos inmunitarios, enfermedad cardiovascular, infección viral, inflamación, trastornos de la función endócrina/metabolismo y trastornos neurológicos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0707088A GB0707088D0 (en) | 2007-04-12 | 2007-04-12 | Pharmaceutical compounds |
GB0707611A GB0707611D0 (en) | 2007-04-19 | 2007-04-19 | Pharmaceutical compounds |
PCT/GB2008/001301 WO2008125839A2 (en) | 2007-04-12 | 2008-04-14 | Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009010886A true MX2009010886A (es) | 2009-12-14 |
Family
ID=39832798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009010886A MX2009010886A (es) | 2007-04-12 | 2008-04-14 | Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100130496A1 (es) |
EP (1) | EP2150546B1 (es) |
JP (1) | JP2010523639A (es) |
KR (1) | KR20100016433A (es) |
CN (1) | CN101765597A (es) |
AT (1) | ATE496045T1 (es) |
AU (1) | AU2008237721A1 (es) |
BR (1) | BRPI0810641A2 (es) |
CA (1) | CA2683624A1 (es) |
DE (1) | DE602008004650D1 (es) |
IL (1) | IL201365A0 (es) |
MX (1) | MX2009010886A (es) |
WO (1) | WO2008125839A2 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100016431A (ko) * | 2007-04-12 | 2010-02-12 | 에프. 호프만-라 로슈 아게 | 약학적 화합물 |
PE20110403A1 (es) | 2008-07-31 | 2011-07-04 | Genentech Inc | Compuestos biciclicos fusionados de pirimidina en el tratamiento del cancer |
KR101354763B1 (ko) * | 2008-08-25 | 2014-01-22 | 아이알엠 엘엘씨 | 헷지호그 경로 조절제 |
TWI378933B (en) | 2008-10-14 | 2012-12-11 | Daiichi Sankyo Co Ltd | Morpholinopurine derivatives |
MX2011008444A (es) | 2009-02-12 | 2011-09-06 | Astellas Pharma Inc | Derivado de heteroanillo. |
WO2011058027A2 (en) | 2009-11-12 | 2011-05-19 | F. Hoffmann-La Roche Ag | N-9-substituted purine compounds, compositions and methods of use |
US8828990B2 (en) | 2009-11-12 | 2014-09-09 | Genentech, Inc. | N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
UA108390C2 (uk) | 2010-08-10 | 2015-04-27 | Астеллас Фарма Інк. | Похідні бензімідазолу та їх застосування |
RU2596185C2 (ru) | 2010-09-29 | 2016-08-27 | Интервет Интернэшнл Б.В. | N-гетероарильные соединения |
EP2813506B1 (en) | 2010-12-16 | 2016-05-25 | F. Hoffmann-La Roche AG | Tricyclic PI3K inhibitor compounds and methods of use |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EA029473B1 (ru) | 2011-12-15 | 2018-03-30 | Новартис Аг | Применение ингибиторов pi3k для лечения острой и церебральной малярии |
AR090545A1 (es) | 2012-03-28 | 2014-11-19 | Intervet Int Bv | Compuesto heteroarilo con una unidad puente aciclica |
KR20160027219A (ko) | 2012-05-23 | 2016-03-09 | 에프. 호프만-라 로슈 아게 | 내배엽 및 간세포를 수득하고 사용하는 조성물 및 방법 |
EP2914260A1 (en) | 2012-10-31 | 2015-09-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for preventing antiphospholipid syndrome (aps) |
BR112016010568B1 (pt) * | 2013-11-15 | 2021-09-21 | Bayer Cropscience Aktiengesellschaft | Processo para preparação de um derivado de 2-etilaminopiridina substituída |
KR102420508B1 (ko) * | 2014-02-21 | 2022-07-13 | 프로스트 바이오로직, 아이엔씨. | 암 및 증식성 장애들의 치료를 위한 유사분열억제성 아마이드들 |
WO2016059220A1 (en) | 2014-10-16 | 2016-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Tcr-activating agents for use in the treatment of t-all |
GB201602527D0 (en) * | 2016-02-12 | 2016-03-30 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
ES2912531T3 (es) | 2016-12-21 | 2022-05-26 | Bayer Cropscience Ag | Hidrogenación de un derivado de 2-metil cianopiridilo sustituido en presencia de un catalizador de cobalto Raney |
JP7352284B2 (ja) * | 2017-05-15 | 2023-09-28 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン | LSD-1インヒビターとしてのピロロ〔2,3-c〕ピリジン及び関連類似体 |
WO2019046316A1 (en) * | 2017-08-28 | 2019-03-07 | Acurastem Inc. | PIKFYVE KINASE INHIBITORS |
GB201810669D0 (en) * | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
CN112047938B (zh) * | 2019-06-06 | 2022-11-22 | 北京泰德制药股份有限公司 | 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物 |
WO2021113506A1 (en) | 2019-12-04 | 2021-06-10 | Chdi Foundation, Inc. | Atm kinase inhibitors and compositions and methods of use thereof |
JP2023513794A (ja) * | 2020-02-14 | 2023-04-03 | ソーク インスティテュート フォー バイオロジカル スタディーズ | Ulk1/2の阻害剤およびその使用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60144322D1 (de) * | 2000-04-27 | 2011-05-12 | Astellas Pharma Inc | Kondensierte heteroarylderivate |
CA2507100C (en) * | 2002-11-21 | 2012-10-09 | Chiron Corporation | 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
WO2005000404A2 (en) * | 2003-05-29 | 2005-01-06 | Synta Pharmaceuticals, Corp. | Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
AU2005244104B2 (en) * | 2004-05-08 | 2012-03-15 | Novartis International Pharmaceutical Ltd. | 4,5-disubstituted-2-aryl pyrimidines |
CA2587590A1 (en) * | 2004-11-19 | 2006-06-08 | Synta Pharmaceuticals Corp. | Pyrimidine compounds and uses thereof |
GB0520657D0 (en) * | 2005-10-11 | 2005-11-16 | Ludwig Inst Cancer Res | Pharmaceutical compounds |
-
2008
- 2008-04-14 EP EP08736964A patent/EP2150546B1/en not_active Not-in-force
- 2008-04-14 CN CN200880019513A patent/CN101765597A/zh active Pending
- 2008-04-14 AT AT08736964T patent/ATE496045T1/de not_active IP Right Cessation
- 2008-04-14 DE DE602008004650T patent/DE602008004650D1/de active Active
- 2008-04-14 BR BRPI0810641A patent/BRPI0810641A2/pt not_active IP Right Cessation
- 2008-04-14 AU AU2008237721A patent/AU2008237721A1/en not_active Abandoned
- 2008-04-14 WO PCT/GB2008/001301 patent/WO2008125839A2/en active Application Filing
- 2008-04-14 MX MX2009010886A patent/MX2009010886A/es not_active Application Discontinuation
- 2008-04-14 JP JP2010502577A patent/JP2010523639A/ja active Pending
- 2008-04-14 US US12/594,529 patent/US20100130496A1/en not_active Abandoned
- 2008-04-14 CA CA002683624A patent/CA2683624A1/en not_active Abandoned
- 2008-04-14 KR KR1020097023504A patent/KR20100016433A/ko not_active Application Discontinuation
-
2009
- 2009-10-11 IL IL201365A patent/IL201365A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2683624A1 (en) | 2008-10-23 |
CN101765597A (zh) | 2010-06-30 |
AU2008237721A1 (en) | 2008-10-23 |
US20100130496A1 (en) | 2010-05-27 |
WO2008125839A3 (en) | 2008-12-24 |
ATE496045T1 (de) | 2011-02-15 |
IL201365A0 (en) | 2010-05-31 |
BRPI0810641A2 (pt) | 2019-09-24 |
KR20100016433A (ko) | 2010-02-12 |
WO2008125839A2 (en) | 2008-10-23 |
EP2150546A2 (en) | 2010-02-10 |
JP2010523639A (ja) | 2010-07-15 |
DE602008004650D1 (de) | 2011-03-03 |
EP2150546B1 (en) | 2011-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009010886A (es) | Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa. | |
MX2009010881A (es) | Compuestos farmaceuticos. | |
GB0423653D0 (en) | Pharmaceutical compounds | |
MX2008013578A (es) | Derivados de tieno [3,2-d]pirimidina utiles como inhibidores de fosfatidilinositol 3-cinasa(p13k). | |
MX2009010884A (es) | 2-morfolin-4-il-pirimidinas como inhibidores de fosfatidilinositol-3-cinasa (pi3k). | |
WO2009053715A8 (en) | Thienopyrimidiene derivatives as pi3k inhibitors | |
PH12014501504A1 (en) | THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES | |
ATE510841T1 (de) | Thiazoliopyrimidine und ihre verwendung als hemmer der phosphatidylinositol-3 kinase | |
SG178591A1 (en) | Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer | |
MX2009009590A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
MX2009010037A (es) | Aminopirimidinas utiles como inhibidores de cinasas. | |
WO2011014795A3 (en) | Compounds and compositions as syk kinase inhibitors | |
MX2010003668A (es) | Derivados de purina sustituidas con primidina. | |
MX2013004298A (es) | Derivados de quinazolin-4 (3h)-ona utilizados como inhibidores de pi3 cinasa. | |
UA99141C2 (ru) | Замещенные производные индазола, активные в качестве ингибиторов киназы | |
WO2010005558A3 (en) | Pi3k isoform selective inhibitors | |
MX2009011950A (es) | Derivados de pirimidina y composiciones como inhibidores de cinasa c-kit y pdgfr. | |
TN2009000444A1 (en) | Combination therapy with a compound acting as a plateletadp receptor inhibitor | |
MX2007013624A (es) | Inhibidores de proteina cinasa. | |
MX2009011811A (es) | Aminopirimidinas utiles como inhibidores de cinasa. | |
MX2010006241A (es) | Derivados de aminotriazol como agonistas de alx. | |
AU2009282962A8 (en) | Compounds as kinase inhibitors | |
MX2012000166A (es) | Compuestos de quinazolina que contienen fosforo y metodos de uso de los mismos. | |
MX2009011059A (es) | Aminopirimidinas utiles como inhibidores de cinasas. | |
WO2011146594A3 (en) | Mtor selective kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |